Dotbee.ai

Analysis NuVim, Inc. (NUVM)

6/5/2024

Analysis NuVim, Inc. (NUVM)

Analysis of NuVim, Inc. (NUVM)

NuVim, Inc. is showing some interesting price movements and technical indicators based on the provided data. Here are some key points from the analysis:

1. **Price Movement**: The closing prices have been fluctuating between 0.005 and 0.0076 over the past few days, indicating some volatility in the stock.

2. **Relative Strength Index (RSI)**: The RSI values have been around 47 to 63, suggesting that the stock is neither overbought nor oversold. This indicates a balanced market sentiment.

3. **Moving Average Convergence Divergence (MACD)**: The MACD line has been fluctuating around the signal line, with the histogram showing mixed signals. This could indicate a potential change in trend.

4. **Moving Averages (MA)**: The stock price has been hovering around the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a consolidation phase.

Overall, NuVim, Inc. appears to be in a consolidation phase with mixed signals from technical indicators. Traders and investors may want to closely monitor the price movements and wait for clearer signals before making any trading decisions.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
6. Investing activities include significant amounts related to the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.

3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.

4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests further growth compared to the EPS of $6.10 for the current fiscal year.

Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and the next fiscal years.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.

Growth estimates

Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.

These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be healthy.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25

Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are both healthy, and the company shows good returns on assets and equity. The fiscal year ends in September 2023, with the most recent quarter ending in March 2024. The company has seen a decline in quarterly revenue and earnings growth year over year.

In terms of stock statistics, there is a low short ratio and a significant percentage of shares held by institutions. The stock has a high price-to-book ratio and price-to-sales ratio, with a relatively high enterprise value. The market capitalization is also substantial.

The stock price summary shows volatility in the stock price over the past year, with a beta above 1. The stock is currently trading below its 50-day and 200-day moving averages, with a 52-week range from a low of 164.08 to a high of 199.62.

Lastly, the company pays dividends with a moderate payout ratio and has a history of stock splits. The forward annual dividend yield is low, and the 5-year average dividend yield is also relatively modest. The next dividend date is in May 2024.

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, the gross profit has generally followed the trend of increasing sales revenue.
3. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
4. Net income has also shown an increasing trend, reaching $97 billion in 2023 from $57.4 billion in 2020.
5. The company has been able to manage its operating expenses effectively, as seen in the consistent growth of operating income.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to generate positive non-operating interest income, contributing to its overall profitability.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.

Balance Sheet

These are balance sheets. Here are the conclusions based on the provided data:

1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2020 at $65,339,000,000.
6. The company has been relying more on non-current liabilities over the years, with the highest value in 2023 at $145,129,000,000.
7. Cash and cash equivalents have been fluctuating, with the highest value in 2019 at $48,844,000,000.
8. Investments and advances have been increasing steadily, with the highest value in 2023 at $100,544,000,000.
9. Machinery, furniture, and equipment have also been increasing, with the highest value in 2023 at $78,314,000,000.
10. Accumulated depreciation has been increasing, indicating the aging of assets over the years.

MACD of NUVM

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link